Updated
Updated · dongascience.com · Aug 23
Nature Flags 54 Senescence Papers for Misusing E. coli Antibodies
Updated
Updated · dongascience.com · Aug 23

Nature Flags 54 Senescence Papers for Misusing E. coli Antibodies

1 articles · Updated · dongascience.com · Aug 23

Summary

  • More than 50 cellular senescence papers appear to have used E. coli β-galactosidase antibodies to detect mammalian proteins, raising doubts about the reliability and reproducibility of their findings.
  • Scholto David identified 54 such papers and said the bacterial antibodies were unlikely to properly recognize β-galactosidase in mammalian cells, a key marker used to identify senescent cells.
  • Nature said the impact now must be assessed paper by paper; one author of a 2010 Cancer Research study said the mistaken antibody was used only in supplementary work and did not alter the main conclusion.
  • The problem fits a broader pattern in life sciences: David has previously linked more than 300 papers to another antibody mix-up, while researchers say confusing product names and weak validation help such errors persist.
  • Aled Edwards warned that incorrect antibody records could also mislead AI systems used for literature mining and disease-target prediction, widening the fallout beyond the original studies.

Insights

How many AI-driven medical breakthroughs are secretly learning from corrupted data caused by wrong antibodies?
Could a simple labeling mix-up quietly invalidate years of groundbreaking cancer and anti-aging research?
If scientists cannot trust their own tools, who is responsible for policing the research supply chain?